TDS

Telephone and Data Systems Inc.

$39.43 +0.82%

Share classes & related securities

TDS is the same company as:

TDSpU TDSpV

Recent alerts on TDS

All signals →

News Streaming and media stocks lead communication services EPS revision rankings

SEC filing TDS Completes $1B Sale of Spectrum Assets to Verizon, Declares $11 Special Dividend on Array Stock

News Diameter Capital Sells All Telephone and Data System Shares

News US Cellular Closes $4.3 Billion Sale

News Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?

News Compared to Estimates, TDS (TDS) Q2 Earnings: A Look at Key Metrics

News IBM, Jones Lang Unite to Boost ESG Reporting in the CRE Sector - Zacks Investment Research

News Telephone and Data Systems (TDS) Sells OneNeck to Boost Fiber

News TDS targets 200,000-250,000 new fiber addresses in 2026 while proposing to acquire remaining Array shares

News Array Digital jumps after Telephone and Data Systems takeover offer, results

Insider trade Sale by Prudence E Carlson

SEC filing TDS Announces Retirement of SVP Joseph Hanley Effective July 1 2026

News Quant check on Dan Loeb-led Third Point's top Q4 holdings: PCG, NVDA, UNP, AMZN

News Mexico’s Fuel-Smuggling Crackdown Hobbles Nation’s Auto Industry

News Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory

News China charges former AstraZeneca executive – what it means for global pharmaceutical firms

News AstraZeneca Earnings: Strong Finish to Year, and Busy Schedule of Data Readouts Ahead - Morningstar Canada

News AstraZeneca Cancer Portfolio Dominates Sales With Massive Double Digit Growth

News AstraZeneca Leans On Its Cancer Division For A Fourth-Quarter Beat

News AstraZeneca Targets Global Obesity Market With Low-Cost Weight-Loss Drugs

News Earnings Snapshot: AstraZeneca beats Q4 revenue estimates; initiates FY outlook

News AstraZeneca’s growth engine stays on track despite cost pressures

News AstraZeneca reports Q4 results

News AstraZeneca Forecasts Continued Growth on Pipeline Strength

News AstraZeneca Sees Further Profit Growth, Lifted by Cancer Drugs

Get push alerts for TDS

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS